Furthermore, recombinant AAV vector-mediated intranigral delivery of parkin prevented motor deficits and dopaminergic cell loss in a chronic MPTP-minipump mouse model of PD (Yasuda et al., 2011). Here, PRKN is linked to Parkinson disease.